On July 30, Amphenol rose 3.12% in pre-market trading, trading at $154.9/share, with turnover of $1.1552 million.

On the news front, Truist raised its price target on Amphenol from $200 to $215, maintaining a Buy rating, marking the first target price upgrade following the company's Q2 earnings release. This follows similar upward revisions from JPMorgan and Barclays, which had set targets in the $198 to $215 range, further consolidating bullish institutional sentiment.

Amphenol reported Q2 results on July 29, with adjusted EPS of $1.35 beating the consensus estimate of $1.18 by 14.4%, and revenue of $8.76 billion surpassing expectations of $8.26 billion. More critically, Q3 guidance came in well above consensus, with projected adjusted EPS of $1.40 to $1.42 versus the $1.27 estimate, and revenue of $9.3 to $9.4 billion versus the $8.67 billion expectation. The stock had previously pulled back over 10% due to systematic sector weakness and pre-earnings caution, and the earnings beat has driven a rapid reversal of prior pessimism.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)